DVA DAVITA INC.

NYSE davita.com


$ 119.25 $ 0.03 (0.03 %)    

Monday, 03-Nov-2025 16:35:49 EST
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 119.05
$ 118.00
$ 115.59 x 86
$ 120.49 x 300
$ 115.64 - $ 119.06
$ 115.39 - $ 179.60
1,363,857
na
8.4B
$ 0.56
$ 10.89
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 02-13-2025 12-31-2024 10-K
5 10-29-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-14-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 10-31-2022 09-30-2022 10-Q
14 08-01-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-11-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 02-12-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 02-21-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-02-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-22-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-03-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-01-2017 06-30-2017 10-Q
35 05-02-2017 03-31-2017 10-Q
36 02-24-2017 12-31-2016 10-K
37 11-02-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-hold-on-davita-lowers-price-target-to-133

TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and lowers the price target from $154 to $133.

 barclays-maintains-equal-weight-on-davita-lowers-price-target-to-143

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price target from $149 to $143.

 davita-narrows-fy2025-adj-eps-guidance-from-1020-1130-to-1035-1115-vs-1086-est

DaVita (NYSE:DVA) narrows FY2025 Adj EPS guidance from $10.20-$11.30 to $10.35-$11.15 vs $10.86 analyst estimate..

 davita-q3-adj-eps-251-misses-322-estimate-sales-3420b-miss-3428b-estimate

DaVita (NYSE:DVA) reported quarterly earnings of $2.51 per share which missed the analyst consensus estimate of $3.22 by 22.1 p...

 barclays-maintains-equal-weight-on-davita-lowers-price-target-to-149

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price target from $160 to $149.

 b-of-a-securities-maintains-underperform-on-davita-lowers-price-target-to-140

B of A Securities analyst Kevin Fischbeck maintains DaVita (NYSE:DVA) with a Underperform and lowers the price target from $...

 whats-going-with-dialysis-firm-davita-stock-on-friday

DaVita reported a ransomware attack affecting 2.7 million patients, posted Q2 earnings above estimates, and authorized a $2 bil...

 davita-board-increases-share-repurchase-program-by-2b

 - SEC Filing

 buffett-reveals-unitedhealth-stake-trims-apple-in-berkshire-hathaway-q2-13f-filing

A look at the updated Berkshire Hathaway portfolio after the second quarter, including a new stake in UnitedHealth.

 berkshire-hathaway-13f-preview-did-buffett-trim-appleand-will-the-mystery-stock-be-revealed

Warren Buffett has requested confidentiality in a new Berkshire Hathaway position. Will investors find out the stock Thursday?

 barclays-maintains-equal-weight-on-davita-lowers-price-target-to-160

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price target from $169 to $160.

 davita-affirms-fy2025-adj-eps-guidance-of-1020-1130-vs-1073-est

DaVita (NYSE:DVA) affirms FY2025 Adj EPS guidance from $10.20-$11.30 to $10.20-$11.30 vs $10.73 analyst estimate..

 davita-q2-adj-eps-295-beats-279-estimate-sales-3380b-beat-3355b-estimate

DaVita (NYSE:DVA) reported quarterly earnings of $2.95 per share which beat the analyst consensus estimate of $2.79 by 5.92 per...

 warren-buffetts-berkshire-hathaway-offloads-230-million-in-davita-stock-ahead-of-q2-earnings

Berkshire Hathaway sold 1.64 million shares of DaVita Inc. for $230 million just before DaVita's Q2 earnings.

 davita-supports-one-year-extension-of-kidney-care-choices-model-citing-long-term-savings-and-improved-patient-outcomes

DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center fo...

 davita-announces-upsize-and-pricing-of-its-previously-announced-private-offering-of-its-6750-senior-notes-due-2033-from-750m-to-1b

DaVita Inc. (NYSE:DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (...

 truist-securities-maintains-hold-on-davita-lowers-price-target-to-164

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and lowers the price target from $170 to $...

 warren-buffett-ditches-bitcoin-linked-nu-holdings-adds-to-constellation-brands-dominos-pizza-pool-corp-stakes

As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION